1189 related articles for article (PubMed ID: 18922683)
1. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
[TBL] [Abstract][Full Text] [Related]
2. Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC/Nga mice.
Murota H; El-latif MA; Tamura T; Amano T; Katayama I
Int Arch Allergy Immunol; 2010; 153(2):121-32. PubMed ID: 20407268
[TBL] [Abstract][Full Text] [Related]
3. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.
Tominaga M; Tengara S; Kamo A; Ogawa H; Takamori K
J Dermatol Sci; 2009 Jul; 55(1):40-6. PubMed ID: 19443185
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.
Schulte-Herbrüggen O; Fölster-Holst R; von Elstermann M; Augustin M; Hellweg R
Int Arch Allergy Immunol; 2007; 144(3):211-6. PubMed ID: 17579279
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis.
Yoshioka T; Hikita I; Asakawa M; Hirasawa T; Deguchi M; Matsutani T; Oku H; Horikawa T; Arimura A
Immunology; 2006 Jul; 118(3):293-301. PubMed ID: 16827890
[TBL] [Abstract][Full Text] [Related]
6. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
7. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis.
Kim HO; Lee CH; Ahn HK; Park CW
Int J Dermatol; 2009 Apr; 48(4):431-8. PubMed ID: 19335435
[TBL] [Abstract][Full Text] [Related]
8. Synergetic effects of prednisolone and olopatadine on atopic dermatitis model of hairless mice.
Kagawa Y; Izawa K; Yano H; Kamei C
Pharmacology; 2010; 85(5):286-94. PubMed ID: 20453552
[TBL] [Abstract][Full Text] [Related]
9. Content of vascular endothelial growth factor in stratum corneum well correlates to local severity of acute inflammation in patients with atopic dermatitis.
Amarbayasgalan T; Takahashi H; Dekio I; Morita E
Int Arch Allergy Immunol; 2012; 157(3):251-8. PubMed ID: 22042099
[TBL] [Abstract][Full Text] [Related]
10. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
11. A Role of Staphyococcus aureus, Interleukin-18, Nerve Growth Factor and Semaphorin 3A, an Axon Guidance Molecule, in Pathogenesis and Treatment of Atopic Dermatitis.
Ikezawa Z; Komori J; Ikezawa Y; Inoue Y; Kirino M; Katsuyama M; Aihara M
Allergy Asthma Immunol Res; 2010 Oct; 2(4):235-46. PubMed ID: 20885908
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice.
Jiang J; Yamaguchi T; Funakushi N; Kuhara T; Fan PS; Ueki R; Suto H; Kase Y; Ikeda S; Ogawa H
J Dermatol Sci; 2009 Oct; 56(1):37-42. PubMed ID: 19647983
[TBL] [Abstract][Full Text] [Related]
13. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
14. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
Gerdes S; Kurrat W; Mrowietz U
Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
[TBL] [Abstract][Full Text] [Related]
15. Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis.
Hachisuka J; Takeuchi S; Kido M; Fukiwake N; Furue M
Int J Dermatol; 2009 Apr; 48(4):374-8. PubMed ID: 19335422
[TBL] [Abstract][Full Text] [Related]
16. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study.
Dou YC; Hagströmer L; Emtestam L; Johansson O
Arch Dermatol Res; 2006 Jun; 298(1):31-7. PubMed ID: 16586073
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis.
Raap U; Werfel T; Goltz C; Deneka N; Langer K; Bruder M; Kapp A; Schmid-Ott G; Wedi B
Allergy; 2006 Dec; 61(12):1416-8. PubMed ID: 17073871
[TBL] [Abstract][Full Text] [Related]
18. Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride.
Hosokawa C; Takeuchi S; Furue M
J Dermatol; 2009 Apr; 36(4):185-90. PubMed ID: 19348655
[TBL] [Abstract][Full Text] [Related]
19. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.
Takano N; Sakurai T; Ohashi Y; Kurachi M
Br J Dermatol; 2007 Feb; 156(2):241-6. PubMed ID: 17223862
[TBL] [Abstract][Full Text] [Related]
20. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
Tamura T; Amano T; Ohmori K; Manabe H
Eur J Pharmacol; 2005 Nov; 524(1-3):149-54. PubMed ID: 16259975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
